Active 0 6 0 6 O
and 7 10 7 10 O
uncontrolled 11 23 11 23 O
relapse 24 31 24 31 O
of 32 34 32 34 O
malignancy 35 45 35 45 B-cancer

Clinical 0 8 46 54 O
status 9 15 55 61 O
at 16 18 62 64 O
enrollment 19 29 65 75 O
to 30 32 76 78 O
allow 33 38 79 84 O
tapering 39 47 85 93 O
of 48 50 94 96 O
steroids 51 59 97 105 B-treatment
equal 60 65 106 111 O
to 66 68 112 114 O
or 69 71 115 117 O
less 72 76 118 122 O
than 77 81 123 127 O
0.5 82 85 128 131 B-upper_bound
mg 86 88 132 134 I-upper_bound
/ 88 89 134 135 I-upper_bound
kg 89 91 135 137 I-upper_bound
/ 91 92 137 138 I-upper_bound
day 92 95 138 141 I-upper_bound
of 96 98 142 144 O
prednisone 99 109 145 155 B-treatment

Failure 0 7 156 163 O
of 8 10 164 166 O
antiviral 11 20 167 176 B-treatment
therapy 21 28 177 184 I-treatment

Optimum 0 7 185 192 B-treatment
therapy 8 15 193 200 I-treatment
is 16 18 201 203 O
defined 19 26 204 211 O
as 27 29 212 214 O
at 30 32 215 217 O
least 33 38 218 223 O
14 39 41 224 226 B-lower_bound
days 42 46 227 231 I-lower_bound
of 47 49 232 234 O
therapy 50 57 235 242 B-treatment
with 58 62 243 247 I-treatment
ganciclovir 63 74 248 259 I-treatment
, 74 75 259 260 O
foscarnet 76 85 261 270 B-treatment
, 85 86 270 271 O
cidofovir 87 96 272 281 B-treatment
, 96 97 281 282 O
or 98 100 283 285 O
valganciclovir 101 115 286 300 B-treatment
for 116 119 301 304 O
patients 120 128 305 313 O
with 129 133 314 318 O
disease 134 141 319 326 O
or 142 144 327 329 O
CMV 145 148 330 333 B-chronic_disease
viremia 149 156 334 341 I-chronic_disease

Patients 0 8 342 350 O
receiving 9 18 351 360 O
prednisone 19 29 361 371 B-clinical_variable
> 30 31 372 373 O
0.5 32 35 374 377 B-lower_bound
mg 36 38 378 380 I-lower_bound
/ 38 39 380 381 I-lower_bound
kg 39 41 381 383 I-lower_bound
/ 41 42 383 384 I-lower_bound
day 42 45 384 387 I-lower_bound
at 46 48 388 390 O
time 49 53 391 395 O
of 54 56 396 398 O
enrollment 57 67 399 409 O

Patients 0 8 410 418 O
who 9 12 419 422 O
can 13 16 423 426 O
not 16 19 426 429 O
tolerate 20 28 430 438 O
standard 29 37 439 447 O
anti 38 42 448 452 B-treatment
- 42 43 452 453 I-treatment
viral 43 48 453 458 I-treatment
therapy 49 56 459 466 I-treatment
and 57 60 467 470 O
can 61 64 471 474 O
not 64 67 474 477 O
continue 68 76 478 486 O
anti 77 81 487 491 B-treatment
- 81 82 491 492 I-treatment
viral 82 87 492 497 I-treatment
treatment 88 97 498 507 I-treatment
due 98 101 508 511 O
to 102 104 512 514 O
side 105 109 515 519 O
effect 110 116 520 526 O
profile 117 124 527 534 O
will 125 129 535 539 O
be 130 132 540 542 O
eligible 133 141 543 551 O
independent 142 153 552 563 O
of 154 156 564 566 O
anti 157 161 567 571 O
- 161 162 571 572 O
viral 162 167 572 577 O
therapy 168 175 578 585 O
duration 176 184 586 594 O

Patients 0 8 595 603 O
with 9 13 604 608 O
CMV 14 17 609 612 B-chronic_disease
disease 18 25 613 620 I-chronic_disease

Patients 0 8 621 629 O
with 9 13 630 634 O
active 14 20 635 641 B-chronic_disease
acute 21 26 642 647 I-chronic_disease
GVHD 27 31 648 652 I-chronic_disease
grades 32 38 653 659 B-lower_bound
II 39 41 660 662 I-lower_bound
- 41 42 662 663 O
IV 42 44 663 665 B-upper_bound

Patients 0 8 666 674 O
with 9 13 675 679 O
or 14 16 680 682 O
without 17 24 683 690 O
a 25 26 691 692 O
malignancy 27 37 693 703 B-cancer

Patients 0 8 704 712 O
with 9 13 713 717 O
other 14 19 718 723 O
uncontrolled 20 32 724 736 O
infections 33 43 737 747 B-chronic_disease

Persistent 0 10 748 758 O
CMV 11 14 759 762 B-chronic_disease
infection 15 24 763 772 I-chronic_disease
despite 25 32 773 780 O
optimum 33 40 781 788 O
anti 41 45 789 793 B-treatment
- 45 46 793 794 I-treatment
viral 46 51 794 799 I-treatment
therapy 52 59 800 807 I-treatment

Relapse 0 7 808 815 O
while 8 13 816 821 O
on 14 16 822 824 O
CMV 17 20 825 828 B-treatment
antiviral 21 30 829 838 I-treatment
therapy 31 38 839 846 I-treatment
defined 39 46 847 854 O
as 47 49 855 857 O
recurrence 50 60 858 868 O
of 61 63 869 871 O
DNAemia 64 71 872 879 O
while 72 77 880 885 O
being 78 83 886 891 O
on 84 86 892 894 O
at 87 89 895 897 O
least 90 95 898 903 O
2 96 97 904 905 B-lower_bound
weeks 98 103 906 911 I-lower_bound
of 104 106 912 914 O
antiviral 107 116 915 924 O
therapy 117 124 925 932 O

any 0 3 933 936 O
type 4 8 937 941 O
of 9 11 942 944 O
autologous 12 22 945 955 B-treatment
or 23 25 956 958 I-treatment
allogeneic 26 36 959 969 I-treatment
HSCT 37 41 970 974 I-treatment

defined 0 7 975 982 O
as 8 10 983 985 O
the 11 14 986 989 O
continued 15 24 990 999 O
presence 25 33 1000 1008 O
of 34 36 1009 1011 O
deoxyribonucleic 37 53 1012 1028 O
acid 54 58 1029 1033 O
( 59 60 1034 1035 O
DNA)emia 60 68 1035 1043 O
( 69 70 1044 1045 O
defined 70 77 1045 1052 O
as 78 80 1053 1055 O
> 81 82 1056 1057 O
= 82 83 1057 1058 O
137 84 87 1059 1062 B-lower_bound
copies 88 94 1063 1069 I-lower_bound
/ 94 95 1069 1070 I-lower_bound
ml 95 97 1070 1072 I-lower_bound
by 98 100 1073 1075 O
polymerase 101 111 1076 1086 B-treatment
chain 112 117 1087 1092 I-treatment
reaction 118 126 1093 1101 I-treatment
[ 127 128 1102 1103 I-treatment
PCR 128 131 1103 1106 I-treatment
] 131 132 1106 1107 I-treatment
) 132 133 1107 1108 O
for 134 137 1109 1112 O
at 138 140 1113 1115 O
least 141 146 1116 1121 O
2 147 148 1122 1123 B-lower_bound
weeks 149 154 1124 1129 I-lower_bound
of 155 157 1130 1132 O
CMV 158 161 1133 1136 B-treatment
antiviral 162 171 1137 1146 I-treatment
therapy 172 179 1147 1154 I-treatment

donor 0 5 1155 1160 B-treatment
lymphocyte 6 16 1161 1171 I-treatment
infusion 17 25 1172 1180 I-treatment
( 26 27 1181 1182 I-treatment
DLI 27 30 1182 1185 I-treatment
) 30 31 1185 1186 I-treatment
or 32 34 1187 1189 O
Campath 35 42 1190 1197 B-treatment
within 43 49 1198 1204 O
28 50 52 1205 1207 B-upper_bound
days 53 57 1208 1212 I-upper_bound
of 58 60 1213 1215 O
enrollment 61 71 1216 1226 O

for 0 3 1227 1230 O
bacterial 4 13 1231 1240 B-chronic_disease
infections 14 24 1241 1251 I-chronic_disease
, 24 25 1251 1252 O
patients 26 34 1253 1261 O
must 35 39 1262 1266 O
be 40 42 1267 1269 O
receiving 43 52 1270 1279 O
definitive 53 63 1280 1290 O
therapy 64 71 1291 1298 B-treatment
and 72 75 1299 1302 O
have 76 80 1303 1307 O
no 81 83 1308 1310 O
signs 84 89 1311 1316 O
of 90 92 1317 1319 O
progressing 93 104 1320 1331 O
infection 105 114 1332 1341 O
for 115 118 1342 1345 O
72 119 121 1346 1348 B-upper_bound
hours 122 127 1349 1354 I-upper_bound
prior 128 133 1355 1360 I-upper_bound
to 134 136 1361 1363 O
enrollment 137 147 1364 1374 O

for 0 3 1375 1378 O
fungal 4 10 1379 1385 B-chronic_disease
infections 11 21 1386 1396 I-chronic_disease
patients 22 30 1397 1405 O
must 31 35 1406 1410 O
be 36 38 1411 1413 O
receiving 39 48 1414 1423 O
definitive 49 59 1424 1434 O
systemic 60 68 1435 1443 B-treatment
anti 69 73 1444 1448 I-treatment
- 73 74 1448 1449 I-treatment
fungal 74 80 1449 1455 I-treatment
therapy 81 88 1456 1463 I-treatment
and 89 92 1464 1467 O
have 93 97 1468 1472 O
no 98 100 1473 1475 O
signs 101 106 1476 1481 O
of 107 109 1482 1484 O
progressing 110 121 1485 1496 O
infection 122 131 1497 1506 O
for 132 135 1507 1510 O
1 136 137 1511 1512 B-upper_bound
week 138 142 1513 1517 I-upper_bound
prior 143 148 1518 1523 I-upper_bound
to 149 151 1524 1526 O
enrollment 152 162 1527 1537 O

have 0 4 1538 1542 O
received 5 13 1543 1551 O
anti 14 18 1552 1556 B-treatment
- 18 19 1556 1557 I-treatment
thymocyte 19 28 1557 1566 I-treatment
globulin 29 37 1567 1575 I-treatment
( 38 39 1576 1577 I-treatment
ATG 39 42 1577 1580 I-treatment
) 42 43 1580 1581 I-treatment

patients 0 8 1582 1590 O
who 9 12 1591 1594 O
are 13 16 1595 1598 O
immunocompromised 17 34 1599 1616 B-chronic_disease
with 35 39 1617 1621 I-chronic_disease
CMV 40 43 1622 1625 I-chronic_disease
infection 44 53 1626 1635 I-chronic_disease

patients 0 8 1636 1644 O
with 9 13 1645 1649 O
ongoing 14 21 1650 1657 O
viral 22 27 1658 1663 B-chronic_disease
infections 28 38 1664 1674 I-chronic_disease

progressing 0 11 1675 1686 O
infection 12 21 1687 1696 O
is 22 24 1697 1699 O
defined 25 32 1700 1707 O
as 33 35 1708 1710 O
hemodynamic 36 47 1711 1722 O
instability 48 59 1723 1734 O
attributable 60 72 1735 1747 O
to 73 75 1748 1750 O
sepsis 76 82 1751 1757 B-chronic_disease
or 83 85 1758 1760 O
new 86 89 1761 1764 O
symptoms 90 98 1765 1773 O
, 98 99 1773 1774 O
worsening 100 109 1775 1784 O
physical 110 118 1785 1793 O
signs 119 124 1794 1799 O
or 125 127 1800 1802 O
radiographic 128 140 1803 1815 O
findings 141 149 1816 1824 O
attributable 150 162 1825 1837 O
to 163 165 1838 1840 O
infection 166 175 1841 1850 O
; 175 176 1850 1851 O
persisting 177 187 1852 1862 O
fever 188 193 1863 1868 O
without 194 201 1869 1876 O
other 202 207 1877 1882 O
signs 208 213 1883 1888 O
or 214 216 1889 1891 O
symptoms 217 225 1892 1900 O
will 226 230 1901 1905 O
not 231 234 1906 1909 O
be 235 237 1910 1912 O
interpreted 238 249 1913 1924 O
as 250 252 1925 1927 O
progressing 253 264 1928 1939 O
infection 265 274 1940 1949 O

